GlassScriptPhysician profile
Terre Q Quinn
NPI 1760521058
$6,032.47
in general payments reported to CMS, 2019-2025
18 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.62 · 2023: $5,464 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,464 · Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,464.09 |
| Food and Beverage | $512.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $5,464.09 | 2023 | |
| Myriad Genetic Laboratories, INC. | $95.69 | 2021-2025 | Precisetumor |
| Janssen Biotech, INC. | $71.18 | 2025 | Tecvayli, Darzalex, Talvey |
| Genzyme Corporation | $65.02 | 2025 | |
| Pfizer INC. | $58.23 | 2025 | |
| Jazz Pharmaceuticals INC. | $28.19 | 2025 | |
| Eisai INC. | $27.68 | 2025 | |
| Davol INC. | $26.70 | 2025 | Arista |
| Tolmar, INC. | $25.22 | 2025 | |
| Daiichi Sankyo INC. | $24.89 | 2025 | Enhertu |
| Incyte Corporation | $24.48 | 2025 | Monjuvi |
| Progenics Pharmaceuticals, INC. | $21.39 | 2025 | |
| Hologic Sales and Service, LLC | $20.76 | 2025 | Magseed, Magtrace |
| Accord Healthcare, INC. | $20.20 | 2025 | |
| American Regent | $18.34 | 2025 | Injectafer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $14.77 | 2025 | |
| Genentech USA, INC. | $13.76 | 2025 | Tecentriq |
| Iovance Biotherapeutics, INC. | $11.88 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terre Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.